Impaired renal graft survival after a positive B-cell flow-cytometry crossmatch

Nephrology Dialysis Transplantation

Volumn 13, Issue 8, 1998, Pages 2059-2064

  Bittencourt, Marcelo C ^a   Rebibou, Jean Michel ^b   Saint Hillier, Yves ^b   Chabod, Jacqueline ^a   Dupont, Isabelle ^a   Chalopin, Jean Marc ^b   Herve, Patrick ^a   Tiberghien, Pierre ^a  

^a ETS de Franche Comte   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

B cell; Flow cytometry crossmatch; Graft survival; Renal transplantation

Indexed keywords

ARTICLE; B LYMPHOCYTE; COMPLEMENT DEPENDENT CYTOTOXICITY; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE;

ANTIBODIES; B-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 0031848758     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.8.2059     Document Type: Article

References (26)

1. Scornik JC. Detection of alloantibodies by flow cytometry: relevance to clinical transplantation. Cytometry 1995; 22: 259-263
2. Scornik JC, Bray RA, Pollack MS et al. Multicenter evaluation of the flow cytometry T-cell crossmatch - Results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists Proficiency Testing Program. Transplantation 1997; 63: 1440-1445
3. Nelson PW, Eschliman P, Shield CF et al. Improved graft survival in cadaveric renal retransplantation by flow crossmatching. Arch Surg 1996; 131: 599-603
4. Kerman RH, Van Bueren CT, Lewis et al. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients. Transplantation 1990; 49: 52-56
5. Mascaretti L, Sioli V, Puglisi G et al. Pretransplant flow cytometry crossmatch in first cadaveric kidney transplants. Transplant Proc 1995; 27: 668-670
6. Ogura K, Terasaki PI, Johnson C et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 1993; 56: 294-298
7. Mahoney RJ, Ault KA, Given SR et al. The flow cytometric crossmatch and early renal transplant loss. Transplantation 1990; 49: 527-535
8. Christiaans MHL, Overhof R, Haaft AT, Nieman F, Hoof JPN, Berg-Loonen EMVD. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunological well-documented renal allograft recipients. Transplantation 1996; 62: 1341-1347
9. Christiaans M, Berg-Loonen EV, Haaft AT, Nieman F, Hooff JV. Effect of flow cytometry, complement-dependent cytotoxicity and auto crossmatch on cadaveric renal transplant outcome. Transplant Proc 1995; 27: 1028-1030
10. Taylor CJ, Chapman JR, Ting A, Morris PJ. Characterization of lymphocytotoxicity antibodies causing a positive crossmatch in renal transplantation. Transplantation 1989; 48: 953-958
11. Phelan DL, Rodey GE, Flye MW, Hanto DW, Anderson CB, Mohanakumar T. Positives B-cell crossmatches: specificity of antibody and graft outcome. Transplant Proc 1989; 21: 687-688
12. Scornik JC, LeFor WM, Cicciarelli JC et al. Hyperacute and acute kidney graft rejection due to antibodies against B cells. Transplantation 1992; 54: 61-64
13. Darke C, Dyer P. Clinical HLA typing by cytotoxicity. In: Dyer P, Middleton D, eds. Histocompatibility testing. A Practical Approach. Oxford University Press, Oxford; 1993: 60-63
14. Scornik JC, Brunson ME, Chaub B, Howard RJ, Pfaff WW. The crossmatch in renal transplantation - Evaluation of flow cytometry as a replacement for standard cytotoxicity. Transplantation 1994; 57: 621-625
15. Talbot D, Cavanagh G, Coates E et al. Improved graft outcome and reduced complications due to flow cytometric crossmatching and DR matching in renal transplantation. Transplantation 1992; 53: 925-928
16. Lazda VA. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B-cell flow cytometry crossmatch. Transplantation 1994; 57: 964-969
17. Talbot D, White M, Shenton BK et al. Flow cytometric crossmatching in renal transplantation - the long term outcome. Transplant Immunol 1995; 3: 352-355
18. Brando B, Sommaruga E. Flow cytometry cross-match. Eur J Histochem 1996; 40 [Suppl 1]: 53-62
19. Horsburgh T, Lycett A, Mistry N et al. Crossmatching for renal transplantation - a 5 year review of different cytotoxic and flow cytometric methods showing importance of the IgG anti-B lymphocyte FACS crossmatch. Transplant Proc 1997; 29: 1458-1459
20. Bryan Cf, Aeder MI, Helling TS, Luger AM, Nelson PW, Pierce GE. Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation. Transplant Proc 1993; 25: 247-250
21. Hourmant M, Bignon JD, Cesbron A, Soulilou JP. Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one-center study. Clin Transplant 1990; 31: 301-309
22. Ting A. Positive crossmatches - when is it safe to transplant? Transplant Int 1989; 2: 2-7
23. Scornik JC, Brunson ME, Howard RJ, Pfaff WW. Alloimmunisation, memory and the interpretation of crossmatch results for renal transplantation. Transplantation 1992; 54: 389-394
24. Karuppan SS, Lindholm A, Moller E. Characterization and signification of donor-reactive cell antibodies in current sera of kidney transplant patients. Transplantation 1990; 49: 510-515
25. Karuppan SS, Lindholm A, Moller E. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching. Transplantation 1992; 53: 666-673
26. Mohanakumar T, Rhodes C, Mendez-Picon G et al. Renal allograft rejection associated with presensitization to HLA-DR antigens. Transplantation 1981; 31: 93-95